also from thinkBiotech:

Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies

DrugPatentWatch.com - Premium Plan
DrugPatentWatch - Online Approved Drug Database


You are viewing the June 2000 archive
Go to the current data set


Instant Access with secure payment processing:

 Drug patentsDrug patent expirationsPatent expirationDrug sales
$235 / One Month $975 / One Year
One Month One Year
Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Applicant - W

Range: 1 - 5

ApplicantTradenameGeneric NameNDAApproval DateTypePatent NumberPatent ExpirationExclusivity Expiration
Wallace LabsAQUATENSENmethyclothiazide017364Approved prior to Jan 1, 1982RX
Wallace LabsASTELINazelastine hydrochloride020114Nov 01, 1996RX NOV 01,2001
Wallace LabsASTELINazelastine hydrochloride020114Nov 01, 1996RX 5,164,194OCT 16,2011
Wallace LabsBEPADINbepridil hydrochloride019001Dec 28, 1990DISCN
Wallace LabsBUTICAPSbutabarbital sodium085381Approved prior to Jan 1, 1982DISCN

 Complete access available with subscription 

   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   
All listed trade names are property of their owners or licensors.
Raw information from FDA Orange Book, USPTO and other sources. Copyright © 2009 thinkBiotech LLC

Back to main search page


[ Home | Free Patent Expiration Bulletin | Pharmaceutical Innovation Dashboard | Media Access | Affiliate Program | Contact ]

Latest Updates:
follow us on Twitter

Bookmark This Site

Drug Patent Expiration Dates

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek independent professional advice before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

All trademarks and applicant names are the property of their respective owners or licensors.